HYPERTENSION IN PREGNANCY

Course overview

HYPERTENSIVE DISORDERS OF PREGNANCY, INCLUDING CHRONIC HYPERTENSION WITH OR WITHOUT SUPERIMPOSED PRE-ECLAMPSIA/ECLAMPSIA, GESTATIONAL HYPERTENSION, PREECLAMPSIA WITH OR WITHOUT SEVERE FEATURE, HEMOLYSIS, ELEVATED LIVER ENZYMES AND LOW PLATELET COUNT (HELLP) SYNDROME OR ECLAMPSIA PRESENT A SIGNIFICANT RISK OF MORBIDITY TO BOTH MOTHER AND FETUS. ALTHOUGH APPROPRIATE PRENATAL CARE WITH CLOSE OBSERVATION TO DETECT SIGNS OF END ORGAN DAMAGE AND PROMPT DELIVERY TO REDUCE OR AVOID ADVERSE EFFECTS HAVE PRODUCED REDUCED MORBIDITY AND MORTALITY, MORBIDITY AND MORTALITY STILL DO OCCUR. WHILE HYPERTENSION ITSELF PRESENTS CONCERNS DURING PREGNANCY, ADVERSE EFFECTS FROM PROGRESSION TO PRE-ECLAMPSIA/ECLAMPSIA ALONG WITH HELLP SYNDROME PRESENT THE PRIMARY CONCERN. THIS ACTIVITY REVIEWS THE EVALUATION AND MANAGEMENT OF HYPERTENSION IN PREGNANCY AND HIGHLIGHTS THE ROLE OF AN INTERPROFESSIONAL TEAM IN EVALUATING AND IMPROVING CARE FOR PATIENTS WITH THIS CONDITION.